Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67176 - 67200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	PAPSS2	9060	upregulated	rosiglitazone results in increased expression of PAPSS2 mRNA	10q23.2-q23.31	A10216
Rosiglitazone	Approved Investigational	PCK1	5105	upregulated	rosiglitazone results in increased expression of PCK1 mRNA	20q13.31	A24129
Rosiglitazone	Approved Investigational	PCK2	5106	downregulated	rosiglitazone results in decreased expression of PCK2 mRNA	14q11.2-q12	A22609
Rosiglitazone	Approved Investigational	PCSK6	5046	downregulated	rosiglitazone results in decreased expression of PCSK6 mRNA	15q26	A22609
Rosiglitazone	Approved Investigational	PDIA5	10954	downregulated	rosiglitazone results in decreased expression of PDIA5 mRNA	3q21.1	A20427
Rosiglitazone	Approved Investigational	PDK4	5166	upregulated	rosiglitazone results in increased expression of PDK4 mRNA	7q21.3	A24109 A22609 A20427
Rosiglitazone	Approved Investigational	PDLIM2	64236	downregulated	rosiglitazone results in decreased expression of PDLIM2 mRNA	8p21.3	A10216
Rosiglitazone	Approved Investigational	PDLIM4	8572	downregulated	rosiglitazone results in decreased expression of PDLIM4 mRNA	5q31.1	A10216
Rosiglitazone	Approved Investigational	PECAM1	5175	downregulated	rosiglitazone results in decreased expression of PECAM1 mRNA	17q23.3	A24104
Rosiglitazone	Approved Investigational	PEX11A	8800	upregulated	rosiglitazone results in increased expression of PEX11A mRNA	15q26.1	A22609
Rosiglitazone	Approved Investigational	PFKFB1	5207	downregulated	rosiglitazone results in decreased expression of PFKFB1 mRNA	Xp11.21	A22609
Rosiglitazone	Approved Investigational	PHLDA2	7262	downregulated	rosiglitazone results in decreased expression of PHLDA2 mRNA	11p15.4	A10216
Rosiglitazone	Approved Investigational	PI4K2B	55300	downregulated	rosiglitazone results in decreased expression of PI4K2B mRNA	4p15.2	A22609
Rosiglitazone	Approved Investigational	PIK3R1	5295	upregulated	rosiglitazone results in increased expression of PIK3R1 mRNA	5q13.1	A4815
Rosiglitazone	Approved Investigational	PKLR	5313	downregulated	rosiglitazone results in decreased expression of PKLR mRNA	1q22	A22609
Rosiglitazone	Approved Investigational	PLA2G12B	84647	downregulated	rosiglitazone results in decreased expression of PLA2G12B mRNA	10q22.1	A22609
Rosiglitazone	Approved Investigational	PLBD1	79887	upregulated	rosiglitazone results in increased expression of PLBD1 mRNA	12p13.1	A10216
Rosiglitazone	Approved Investigational	PLCXD1	55344	downregulated	rosiglitazone results in decreased expression of PLCXD1 mRNA	Xp22.33 and Yp11.32	A22609
Rosiglitazone	Approved Investigational	PLIN1	5346	upregulated	rosiglitazone results in increased expression of PLIN1 mRNA	15q26.1	A22609
Rosiglitazone	Approved Investigational	PLIN2	123	upregulated	rosiglitazone results in increased expression of PLIN2 mRNA	9p22.1	A23649 A21665 A22609 A20427
Rosiglitazone	Approved Investigational	PLIN4	729359	upregulated	rosiglitazone results in increased expression of PLIN4 mRNA	19p13.3	A22609
Rosiglitazone	Approved Investigational	PLPP1	8611	upregulated	rosiglitazone results in increased expression of PLPP1 mRNA	5q11.2	A22609
Rosiglitazone	Approved Investigational	PLPP3	8613	upregulated	rosiglitazone results in increased expression of PLPP3 mRNA	1p32.2	A10216
Rosiglitazone	Approved Investigational	POLR1E	64425	upregulated	rosiglitazone results in increased expression of POLR1E mRNA	9p13.2	A22609
Rosiglitazone	Approved Investigational	PON1	5444	downregulated	rosiglitazone results in decreased expression of PON1 mRNA	7q21.3	A22609

Displaying entries 67176 - 67200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability